West Pharmaceutical Services Honored with Heart of Pharma Award
West Pharmaceutical Services, Inc. (NYSE: WST), a trailblazer in innovative solutions for injectable drug administration, has achieved significant recognition with the Heart of Pharma Award at the recent CPHI Awards. This prestigious recognition is a testament to their enduring partnership with Fox Chase Cancer Center, highlighting the commitment to philanthropic, ethical, and community-focused initiatives.
A Commitment to Philanthropy
West has been a dedicated philanthropic partner of Fox Chase Cancer Center for over twenty years. This collaboration is centered on improving healthcare access and outcomes for communities. The company made a bold pledge in 2021 to support the launch of a modern mobile screening unit. This initiative builds upon Fox Chase's extensive experience in mobile cancer screening over three decades.
Enhancing Cancer Screening Access
The newly approved mobile screening unit, funded through efforts by West’s dedicated team, is set to enhance cancer screening capabilities significantly. It will enable Fox Chase to provide vital screenings in areas with limited access to healthcare services. The unit will offer advanced cancer screening options, including 3D mammography and additional services like vaccine distribution, phlebotomy, and the collection of vital data for cancer research purposes.
Leadership Voices Support
Eric Green, the President and CEO of West, expressed gratitude for the award, stating, "We are honored to receive this recognition from CPHI and grateful to serve as a partner with Fox Chase Cancer Center, helping to make a difference in the fight against cancer." He emphasized West's ongoing commitment to enhancing community health through their collaboration.
Support from Fox Chase Cancer Center
Robert Uzzo, MD, MBA, President and CEO of Fox Chase Cancer Center, also expressed heartfelt congratulations to West for the recognition. He noted that philanthropy plays a crucial role in achieving their mission for the community and emphasized West's generous support throughout their partnership.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. stands as a leading provider of high-quality injectable solutions and services. As a trustworthy partner for both established and emerging drug developers, West ensures safe and effective containment and delivery of critical medicines. With a robust workforce exceeding 10,000 employees across 50 global sites, the company delivers around 43 billion components and devices annually.
Financial Performance
Headquartered in Exton, Pennsylvania, West generated impressive net sales of $2.95 billion in its fiscal year 2023. It is publicly traded on the New York Stock Exchange (NYSE: WST) and is a constituent of the esteemed Standard & Poor's 500 index. The company's continued growth and commitment to innovation are evident in its operations and partnerships.
Frequently Asked Questions
What is the Heart of Pharma Award?
The Heart of Pharma Award recognizes companies and initiatives committed to philanthropic and community-based initiatives in the pharmaceutical industry.
Who is West Pharmaceutical Services?
West Pharmaceutical Services, Inc. is a global leader in injectable drug delivery solutions, supporting drug developers worldwide in delivering safe and effective medicines.
Why was West awarded the Heart of Pharma Award?
West received the award for its long-term philanthropic partnership with Fox Chase Cancer Center aimed at improving cancer screening access and community health.
What is the significance of the mobile screening unit?
The mobile screening unit enables increased access to cancer screenings, especially in underserved communities, while also integrating advanced technologies for better patient outcomes.
Where can I find more information about West?
For additional details about West Pharmaceutical Services, you can visit their official website.
